A Case of Olanzapine Resistance from Heavy Smoking and Clinical Considerations

Autores/as

  • Kamalakar Surineni University of Kansas SMO
  • Andrew Smith
  • Rachel Glein
  • Nolan Schrader

DOI:

https://doi.org/10.17161/kjm.vol18.22846

Palabras clave:

Olanzapine, Heavy Smoking, Cytochrome P450,, Enzyme Induction

Métricas

##plugins.generic.paperbuzz.sourceName.fileDownloads##
149
Feb 19 '25Feb 22 '25Feb 25 '25Feb 28 '25Mar 01 '25Mar 04 '25Mar 07 '25Mar 10 '25Mar 13 '25Mar 16 '255.0
|

Descargas

Publicado

2025-02-17

Número

Vol. 18 Núm. 1 (2025): Jan. - Feb.

Sección

Case Reports

Licencia

Derechos de autor 2025 Kamalakar Surineni, M.D., MPH, Andrew Smith, B.S., Rachel Glein, B.S., Nolan Schrader, B.S.

Creative Commons License

Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-SinDerivadas 4.0.

All articles in the Kansas Journal of Medicine are licensed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives License (CC-BY-NC-ND 4.0). 

 

Cómo citar

Surineni, K., Smith, A., Glein, R., & Schrader, N. (2025). A Case of Olanzapine Resistance from Heavy Smoking and Clinical Considerations. Kansas Journal of Medicine, 18(1), 21-22. https://doi.org/10.17161/kjm.vol18.22846